Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 100, Issue 1, Pages E26-E29Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2012.12.018
Keywords
Statin; Atorvastatin; Rosuvastatin; Diabetic nephropathy; Podocyte; Urinary podocyte
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labor and Welfare
- Grants-in-Aid for Scientific Research [24591312, 23591297] Funding Source: KAKEN
Ask authors/readers for more resources
We examined the effects of atorvastatin on urinary podocyte excretion. Thirteen patients with type 2 diabetes receiving 2.5 mg of rosuvastatin were recruited and the medication was switched to 10 mg of atorvastatin for a 24-week period. With the switch to atorvastatin, the urinary excretion of podocytes was significantly reduced. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
